DE69202715T2 - Verfahren zur Herstellung von Ethern. - Google Patents

Verfahren zur Herstellung von Ethern.

Info

Publication number
DE69202715T2
DE69202715T2 DE69202715T DE69202715T DE69202715T2 DE 69202715 T2 DE69202715 T2 DE 69202715T2 DE 69202715 T DE69202715 T DE 69202715T DE 69202715 T DE69202715 T DE 69202715T DE 69202715 T2 DE69202715 T2 DE 69202715T2
Authority
DE
Germany
Prior art keywords
stands
residue
hydrocarbon residue
aromatic
compound
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69202715T
Other languages
English (en)
Other versions
DE69202715D1 (de
Inventor
Miichiro Arita
Yukio Mizuno
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Takeda Pharmaceutical Co Ltd
Original Assignee
Takeda Chemical Industries Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Takeda Chemical Industries Ltd filed Critical Takeda Chemical Industries Ltd
Application granted granted Critical
Publication of DE69202715D1 publication Critical patent/DE69202715D1/de
Publication of DE69202715T2 publication Critical patent/DE69202715T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/28Radicals substituted by singly-bound oxygen or sulphur atoms
    • C07D213/30Oxygen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyridine Compounds (AREA)
DE69202715T 1991-03-25 1992-03-16 Verfahren zur Herstellung von Ethern. Expired - Lifetime DE69202715T2 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP6020891 1991-03-25

Publications (2)

Publication Number Publication Date
DE69202715D1 DE69202715D1 (de) 1995-07-06
DE69202715T2 true DE69202715T2 (de) 1995-11-23

Family

ID=13135502

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69202715T Expired - Lifetime DE69202715T2 (de) 1991-03-25 1992-03-16 Verfahren zur Herstellung von Ethern.

Country Status (6)

Country Link
US (1) US5554758A (de)
EP (1) EP0506273B1 (de)
AT (1) ATE123278T1 (de)
CA (1) CA2063851C (de)
DE (1) DE69202715T2 (de)
IE (1) IE67346B1 (de)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5952509A (en) * 1996-06-27 1999-09-14 Takeda Chemical Industries, Ltd. Production of benzaldehyde compounds
US6756360B1 (en) 1998-12-24 2004-06-29 Metabasis Therapeutics, Inc. Combination of FBPase inhibitors and insulin sensitizers for the treatment of diabetes
US7563774B2 (en) 2000-06-29 2009-07-21 Metabasis Therapeutics, Inc. Combination of FBPase inhibitors and antidiabetic agents useful for the treatment of diabetes
WO2004000810A1 (en) * 2002-06-19 2003-12-31 Eos Eczacibasi Ozgun Kimyasal Urunler Sanyi Ve Ticaret A.S. A process for the production of substituted phenyl ethers
US7230016B2 (en) 2003-05-13 2007-06-12 Synthon Ip Inc. Pioglitazone salts, such as pioglitazone sulfate, and pharmaceutical compositions and processes using the same
US20070078170A1 (en) * 2003-08-28 2007-04-05 Khanduri Chandra H Process for the preparation of pioglitazone
WO2005080387A2 (en) 2004-02-20 2005-09-01 Synthon B.V. Processes for making pioglitazone and compounds of the processes
WO2012153312A1 (en) 2011-05-11 2012-11-15 Ranbaxy Laboratories Limited Process for the purification of pioglitazone

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1218326B (it) * 1982-07-23 1990-04-12 Montedison Spa 1-fenossi (feniltio)-4-arilalchinil ossi-benzene derivati ad azione ormonica giovanile ed acaricida
HU186654B (en) * 1982-12-28 1985-09-30 Richter Gedeon Vegyeszet Process for producing new pyridine derivatives, acid additional salts and quaternary salts and pharmaceutical compositions containing them
US4812570A (en) * 1986-07-24 1989-03-14 Takeda Chemical Industries, Ltd. Method for producing thiazolidinedione derivatives
GB8820389D0 (en) * 1988-08-26 1988-09-28 Beecham Group Plc Novel compounds

Also Published As

Publication number Publication date
US5554758A (en) 1996-09-10
ATE123278T1 (de) 1995-06-15
DE69202715D1 (de) 1995-07-06
EP0506273B1 (de) 1995-05-31
EP0506273A2 (de) 1992-09-30
IE920867A1 (en) 1992-10-07
CA2063851C (en) 2003-06-24
EP0506273A3 (en) 1993-01-13
CA2063851A1 (en) 1992-09-26
IE67346B1 (en) 1996-03-20

Similar Documents

Publication Publication Date Title
CA2036808A1 (en) 3-hydroxy-2-cyclobuten-1-one salts, their production and use
TW255891B (de)
EP0738703A3 (de) Acryl-Säure-Derivate, Verfahren zur Herstellung von Acryl-Säure-Derivaten und Acryl-Säure-Polymere
ES471716A1 (es) Procedimiento para la preparacion de esteres n-sustituidos de acidos 9,10-dihidrolisergicos
DE69202715T2 (de) Verfahren zur Herstellung von Ethern.
HUT43605A (en) Process for production of derivatives of heteroaryloxibeta-carboline
ES468897A1 (es) Procedimiento para la obtencion de derivados de urea.
CA2098989A1 (en) Process and intermediates for preparing azabicyclo(2.2.2)octan-3-imines
DE69024546D1 (de) Verfahren zur herstellung von amidoxim-derivaten
TW238304B (en) A process for the preparation of 1-substituted-5(4H)-tetrazolinones
EP0315973A3 (de) Sialocylglycerolipide und Verfahren zu ihrer Herstellung
CA2059647A1 (en) Thiocylating reagents and intermediates, thiopeptides, and methods for preparing and using same
ES469703A1 (es) Procedimiento de preparacion de derivados de piridina.
CA2263268A1 (en) Process for the preparation of 3-amino-2-hydroxy-1-propyl ethers
TW197412B (de)
US5247096A (en) Process for preparing n-tert-butoxycarbonylmaleimide
CS9100950A2 (en) Method of n-succinimidylcarbonates production
ES8606368A1 (es) Un procedimiento para producir un derivado de bencil-fosfi- nato etilico
EP0500952A4 (en) Process for producing nitrogenous heterocycle
ES8609297A1 (es) Procedimiento de preparar aminolactonas
EP1132375A4 (de) Derivate der aminoacryl-säure und ein verfahren zur herstellung derselben
DK0406790T3 (da) Fremgangsmåde til fremstilling af penemer
JPS6440463A (en) Novel nitrobenzene derivative
HUT43855A (en) Process for production of derivatives of cef-3-em-4-carbonic acid
WO2003019383A8 (en) Crystalline aluminophosphate production process and crystalline aluminophosphate

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8327 Change in the person/name/address of the patent owner

Owner name: TAKEDA PHARMACEUTICAL CO. LTD., OSAKA, JP